Drawing for COLD-FIX

USPTO serial 79216156

COLD-FIX

Reviewed by CopyMark Law Group

Reg. 6076998Status 700Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
EVANKO, PATRICIA MALESARDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Deadline: June 16th, 2026

Need help with COLD-FIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infection diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses (varicella, infectious mononucleosis); antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, espiratory viruses; pharmaceutical preparations for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infection diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 16, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 1, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 14, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 3, 2020FIMPFINAL DISPOSITION PROCESSED—
Sep 16, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
May 8, 2020OP.TOPPOSITION TERMINATED NO. 999999—
May 8, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Apr 22, 2020LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Apr 2, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 1, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 13, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 13, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 8, 2018RFNTREFUSAL PROCESSED BY IB—
May 17, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
May 16, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
May 16, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
May 4, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 13, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 3, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 27, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 14, 2017RFNTREFUSAL PROCESSED BY IB—
Sep 25, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 25, 2017RFRRREFUSAL PROCESSED BY MPU—
Sep 20, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 13, 2017DOCKASSIGNED TO EXAMINER—
Sep 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 7, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance